Honey probiotic: Meluka Australia unveils new launch and reassures investors over COVID-19 impact

By Tingmin Koe contact

- Last updated on GMT

Meluka Australia's new launch, the Raw Probiotic Concentrate with Native Honey and Lemon.
Meluka Australia's new launch, the Raw Probiotic Concentrate with Native Honey and Lemon.

Related tags: Honey, Probiotic, Australia

Meluka Australia, the subsidiary of ASX listed Eve Investment, has launched a new product – a Meluka honey and probiotic tonic – said to be the first-of-its-kind in the domestic market.

The product is also launched in the US.

Sharing a similar name with the famous Manuka honey, Meluka honey is produced from bees that harvest from the Melaleuca Alternifolia species of the tea tree, while the former is produced from bees that harvest from the Leptospermum Scoparim species of the tea tree. 

The Meluka honey probiotic tonic contains six probiotic strains, namely lactobacillus acidophilus, lactobacillus casei, lactobacillus plantarum, lactobacillus bulgaricus, bifidobacterium lactis, and saccharomyces cerevisiae.

It claims to benefit the gut and could be taken on its own, mixed with water or added to drinks and smoothies.

Ben Rohr, COO of Eve Investments and CEO of Meluka Australia, told NutraIngredients-Asia ​that the launch was to take the medicinal angle of the company’s honey products further.

This is on top of the other honey products that the company has in its portfolio, such as the tea-tree infused honey and native wildflower honey – also its best-seller.

“We realised that through the explosion of a lot of these fermented drinks, as well as the explosion in the use of probiotics, generally in the tablet form, there was an opportunity to leverage our honey which has its natural sugar that ferment really well.

“It also provides an interesting delicious flavour. It kind of captures the all-in-one solution rather than having to take maybe kombucha and also a probiotic tablet.”

He said that each strain was added at five different stages of the bio-fermentation process – which in its entirely could take two to three months.

The product was launched in Australia in mid-March and a stock was on its way to the US during end March, early April for sale on the company’s website and Amazon.

He added that the company had beefed up its production only within two weeks of launch and there were plans to introduce other flavours on top of the current lemon-flavoured product.

Firms are increasingly interested in exploring probiotics in the form of functional foods to overcome issues such as pill fatigue.

China firm ICS Biological Technology is one example which has launched a probiocoffetics​ – which is a coffee created by fermenting coffee beans with probiotics.

Aussie start-up Kréol, ​on the other hand, has developed a line of dual-strain sparkling probiotic beverages​ for supporting the gut health.


Meanwhile, Meluka Australia has also reassured shareholders that its supply chains to China and the US remained fully operational despite the COVID-19 outbreak.

The company had sent three pellets of its raw organic honey products recently and on the fourth week of March, a pellet of its newest product – a probiotic concentrate with Meluka honey which claims to support gut health – to the US.

For China, its shipment of 21,144 units of honey was sent out in early March and this was followed by another order of 57,600 units of its tea tree oil in the same month.

This is despite how COVID-19 has paralysed much of the world’s supply chain and production operations.

To do so, the company has contracted additional freight and logistics services to ensure exports were maintained, the company said in latest ASX statement released on Mar 26.

It has also beefed up its production by running two shifts per day.

Vertically integrated benefits

Rohr said that being vertically integrated has helped to mitigate supply chain challenges brought by the COVID-19 disruption.

“We manufacture most of our products, we are pretty much vertically integrated as a company where we control each part of the supply chain.

“It is in times like this that this really becomes a big benefit, because we can lockdown a lot of the risk ourselves by good management of staff.”

Nonetheless, he acknowledged that how deliveries would take a longer time.

“Obviously with what's happening in the US, deliveries are taking a little bit longer, but really, overall its being a minor impact at this point.”​ 

Related news

Show more

Related products

show more

Covid-19: A Game Changer for Probiotics

Covid-19: A Game Changer for Probiotics

Lumina Intelligence | 09-Feb-2021 | Technical / White Paper

This free whitepaper from Lumina Intelligence examines how the pandemic has impacted post-purchase consumer engagement with probiotics, the role of probiotics...

Technical Brochure: AnthoC3™ for eye health

Technical Brochure: AnthoC3™ for eye health

AVIDA HEALTH PTE LTD | 18-Jan-2021 | Data Sheet

AnthoC3™ is a proprietary functional ingredient developed by Avida Health for improving eye health. It is rich in proanthocyanidins and anthocyanins from...

Related suppliers

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast